Children’s Liver Tumour European Research Network

Informations projet

ChiLTERN

N° de convention de subvention: 668596

DOI

10.3030/668596

Projet clôturé

Date de signature de la CE 7 Decembre 2015

Date de début 1 Janvier 2016

Date de fin 31 Decembre 2021

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total

€ 8 191 665,00

Contribution de l’UE

€ 7 941 665,00

Coordonné par

THE UNIVERSITY OF BIRMINGHAM
United Kingdom

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Websites, patent fillings, videos etc. (2)

Registration in ISRCTN

Indicates successful registration of the trial on a publically accessible database.

Website activation

Documents, reports (7)

Project Management
Trial publication report

Trial Publication report report month 60 Report detailing the trial publications to date and and plan for future publications

Protocol finalisation and submission to EC.

Indicates successful development of key trial documents. Submission to EC in accordance with EC H2020 clinical trial requirements.

Project Data Management Plan
Dissemination and Communication Plan: and updated regularly

To document clearly how information about CHILTERN will be disseminated to all partners and participants during the project. This will also involve WP leads who will be responsible for providing information about their WP.

Protocols for standardised collection of clinical samples and sample analysis
Publication Policy

To document clearly how the results from all the work packages will made available to the appropriate audiences; including clinicians, researchers, patients and the public

Publications

Peer reviewed articles (9)

Hepatoblastoma and Paediatric Hepatocellular Carcinoma: An Update

Auteurs: Sarangarajan Ranganathan, Dolores Lopez-Terrada, Rita Alaggio
Publié dans: Pediatr Dev Pathol, Numéro Mar-Apr 2020;23(2), 2020, Page(s) 79-95, ISSN 1093-5266
Éditeur: Springer Verlag
DOI: 10.1177/1093526619875228

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications

Auteurs: Carrillo-Reixach et al, J Hepatol,
Publié dans: Hepatol, Numéro 2020, 2020, ISSN 0168-8278
Éditeur: Elsevier BV
DOI: 10.1016/j.jhep.2020.03.025

Bridging molecular basis, prognosis, and treatment of pediatric liver tumors

Auteurs: C Armengol, S Cairo, R Kappler.
Publié dans: Hepatoma Res, Numéro 7:50, 2021, ISSN 2394-5079
Éditeur: OAE Publishing Inc

A combined clinical and biological risk score predicts outcome in hepatoblastoma patients.

Auteurs: Cairo S., Armengol C., Maibach R., Häberle B., Becker K., Carrillo-Reixach J., Guettier C., Vokuhl C., Schmid I., Buendia M.-A., Branchereau S., von Schweinitz D., Kappler R
Publié dans: Eur. J. Cancer, Numéro 141, 2020, Page(s) 30-39, ISSN 0959-8049
Éditeur: Pergamon Press Ltd.
DOI: 10.1016/j.ejca.2020.09.026

Focal Adhesion Kinase (FAK) Over-expression and Prognostic Implication in Paediatric Hepatocellular Carcinoma

Auteurs: Paola Francalanci, Isabella Giovannoni, Cristiano De Stefanis, Ilaria Romito, Chiara Grimaldi, Aurora Castellano, Rita Alaggio, Anna Alisi
Publié dans: J Mol Sci, Numéro Aug 12;21(16):E5795, 2020, ISSN 1422-0067
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms21165795

SP8 Promotes an Aggressive Phenotype in Hepatoblastoma via FGF8 Activation

Auteurs: Wagner AE, Schwarzmayr T, Haberle B, Vokuhl C, Schmid I, Kaller M, Hermeking H, von Schweinitz D, Kappler R
Publié dans: Cancers, Numéro 12 (8), 2020, Page(s) 2294, ISSN 2072-6694
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12082294

A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era.

Auteurs: Stefan M. Pfister, Miguel Reyes-Múgica, John K.C. Chan, Henrik Hasle, Alexander J. Lazar, Sabrina Rossi, Andrea Ferrari, Jason A. Jarzembowski, Kathy Pritchard-Jones, D. Ashley Hill, Thomas S. Jacques, Pieter Wesseling, Dolores H. López Terrada, Andreas von Deimling, Christian P. Kratz, Ian A. Cree and Rita Alaggio
Publié dans: Cancer Discov, Numéro Dec 17, 2021, ISSN 2159-8274
Éditeur: American Association for Cancer Research Inc.

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma

Auteurs: Laura Torrens, Jordi Abril-Fornaguera, Juan Carrillo-Reixach, Alex Rialdi, Ugne Balaseviciute, Carla Montironi, Philipp Haber, Álvaro del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas Akers, Catherine E. Willoughby, Miguel Torres-Martin, Marc Puigvehi, Roser Pinyol, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincen
Publié dans: Cancer Research (under review), Numéro 7/12/2021, 2021, ISSN 0008-5472
Éditeur: American Association for Cancer Research

A LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ ERK and Wnt/Beta-Catenin Pathways

Auteurs: Nicola Mosca, Fatma Zohra Khoubai, Sandrine Fedou, Juan Carrillo-Reixach, Stefano Caruso, Alvaro Del Rio-Alvarez, Emeric Dubois, Christophe Avignon,Nathalie Dugot-Senant, Catherine Guettier, Charlotte Mussini, Jessica Zucman-Rossi, Carolina Armengol, Pierre Thiébaud, Philippe Veschambre, Christophe François Grosset
Publié dans: Liver Cancer, Numéro in press - already published online, 2021, ISSN 2235-1795
Éditeur: Karger